Longitudinal Modeling of Informatively Censored Patient-Reported Outcomes Data in Oncology: Application to a Phase Iii Clinical Trial of Non-Small Cell Lung Cancer
Application to a Phase Iii Clinical Trial of Non-Small Cell Lung Cancer [MEETING ABSTRACT PCN139]
Houghton, K., Boye, M., Bowman, L., Brown, J., & Stull, D. (2016). Longitudinal Modeling of Informatively Censored Patient-Reported Outcomes Data in Oncology: Application to a Phase Iii Clinical Trial of Non-Small Cell Lung Cancer: Application to a Phase Iii Clinical Trial of Non-Small Cell Lung Cancer [MEETING ABSTRACT PCN139]. Value in Health, 19(3), A158-AA159. https://doi.org/10.1016/j.jval.2016.03.1473
Abstract
This is the first known example that directly demonstrates how PRO response is associated with OS through use of joint latent-variable PMM. Moreover, results show that use of PMM with OS analyses provides a greater understanding of treatment effect.
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.